Literature DB >> 25694980

Minimally invasive reoperative aortic valve replacement.

Elisa Mikus1, Simone Calvi1, Alberto Tripodi1, Luca Dozza1, Mauro Lamarra1, Mauro Del Giglio1.   

Abstract

The operative mortality associated with repeat heart valve surgery is supposedly higher than the mortality associated with the primary operation. However, controversy still surrounds the risk factors and optimal surgical approach for patients requiring repeat cardiac surgery, particularly for those requiring aortic valve replacements (AVR). While the standard approach generally utilizes full sternotomy and peripheral cannulation, alternative approaches such as minimally invasive sternotomy may play an increasingly important role in this field. This study compares the advantages and disadvantages of a minimally invasive approach in redo AVR with the standard approach, highlighting difficulties and potential solutions.

Entities:  

Keywords:  Minimally invasive surgery; aortic valve reoperation; unclamped patent internal mammary artery

Year:  2015        PMID: 25694980      PMCID: PMC4311165          DOI: 10.3978/j.issn.2225-319X.2014.11.09

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  21 in total

1.  Reoperative aortic valve replacement: partial upper hemisternotomy versus conventional full sternotomy.

Authors:  J G Byrne; S F Aranki; G S Couper; D H Adams; E N Allred; L H Cohn
Journal:  J Thorac Cardiovasc Surg       Date:  1999-12       Impact factor: 5.209

2.  Mid-term results of aortic valve surgery in redo scenarios in the current practice: results from the multicentre European RECORD (REdo Cardiac Operation Research Database) initiative†.

Authors:  Francesco Onorati; Fausto Biancari; Marisa De Feo; Giovanni Mariscalco; Antonio Messina; Giuseppe Santarpino; Francesco Santini; Cesare Beghi; Giannantonio Nappi; Giovanni Troise; Theodor Fischlein; Giancarlo Passerone; Juni Heikkinen; Giuseppe Faggian
Journal:  Eur J Cardiothorac Surg       Date:  2014-03-30       Impact factor: 4.191

3.  Do you need to clamp a patent left internal thoracic artery-left anterior descending graft in reoperative cardiac surgery?

Authors:  Robert L Smith; Peter I Ellman; Peter W Thompson; Micah E Girotti; Bret A Mettler; Gorav Ailawadi; Benjamin B Peeler; John A Kern; Irving L Kron
Journal:  Ann Thorac Surg       Date:  2009-03       Impact factor: 4.330

Review 4.  Is a minimally invasive approach for re-operative aortic valve replacement superior to standard full resternotomy?

Authors:  Andrés M Pineda; Orlando Santana; Gervasio A Lamas; Joseph Lamelas
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-07

5.  Minimally invasive approach for aortic valve operations.

Authors:  D M Cosgrove; J F Sabik
Journal:  Ann Thorac Surg       Date:  1996-08       Impact factor: 4.330

6.  Minimally invasive redo aortic valve replacement.

Authors:  R K Tam; R B Garlick; A A Almeida
Journal:  J Thorac Cardiovasc Surg       Date:  1997-10       Impact factor: 5.209

Review 7.  Minimally invasive reoperative aortic valve replacement: a systematic review and meta-analysis.

Authors:  Kevin Phan; Jessie J Zhou; Nithya Niranjan; Marco Di Eusanio; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2015-01

8.  Outcomes of reoperative aortic valve replacement via right mini-thoracotomy versus median sternotomy.

Authors:  Andrés M Pineda; Orlando Santana; Javier Reyna; Alejandro Sarria; Gervasio A Lamas; Joseph Lamelas
Journal:  J Heart Valve Dis       Date:  2013-01

Review 9.  Reoperative minimal access aortic valve replacement.

Authors:  Tsuyoshi Kaneko; Marzia Leacche; John Byrne; Lawrence Cohn
Journal:  J Thorac Dis       Date:  2013-11       Impact factor: 2.895

10.  Aortic valve replacement by ministernotomy in redo patients with previous left internal mammary artery patent grafts.

Authors:  Roberto Gaeta; Salvatore Lentini; Giuseppe Raffa; Carlo Pellegrini; Giuseppe Zattera; Mario Viganò
Journal:  Ann Thorac Cardiovasc Surg       Date:  2010-06       Impact factor: 1.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.